1,2-distearoyllecithin has been researched along with Leishmaniasis, Visceral in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, N; Maji, M; Mazumder, S | 1 |
Ali, N; Bhowmick, S; Ravindran, R | 1 |
2 other study(ies) available for 1,2-distearoyllecithin and Leishmaniasis, Visceral
Article | Year |
---|---|
Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection.
Topics: Adjuvants, Immunologic; Animals; Cord Factors; Cytokines; Disease Models, Animal; Female; Humans; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Liposomes; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Nitric Oxide; Phosphatidylcholines; Th1 Cells; Vaccination; Vaccines, Synthetic | 2011 |
gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Immunologic; Immunoglobulin G; Interferon-gamma; Interleukin-4; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Liposomes; Liver; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Spleen; T-Lymphocyte Subsets; Th1 Cells; Time Factors | 2008 |